Ventria provides recombinant proteins derived from the rice plant for medical use
Pixabay / Pexels.com
11 February 2025NewsAmericasLiz Hockley
Fed Circ ruling on Wuhan import ban shakes up economic prong analysis
Key ruling in favour of Kansas-based biotech on genetically engineered proteins from China | Court supports ITC position | Small market segments can be substantial enough for domestic industry requirement.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
17 June 2026 A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.
12 June 2026 In a strong response to BioNTech, Moderna argues its next-gen vaccine is built on a fundamentally different design from the German biotech’s—setting up a scrap over whether a key patent should have been granted.